Compare LFTO & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LFTO | MMSI |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.1B |
| IPO Year | 2026 | 1996 |
| Metric | LFTO | MMSI |
|---|---|---|
| Price | $18.87 | $90.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $98.88 |
| AVG Volume (30 Days) | 895.6K | ★ 1.1M |
| Earning Date | N/A | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | 0.27 | ★ 1.33 |
| Revenue | N/A | ★ $1,515,906,000.00 |
| Revenue This Year | N/A | $8.85 |
| Revenue Next Year | N/A | $5.88 |
| P/E Ratio | $70.96 | ★ $67.88 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $18.11 | $59.74 |
| 52 Week High | $27.94 | $94.75 |
| Indicator | LFTO | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 40.39 | 68.18 |
| Support Level | $18.11 | $89.13 |
| Resistance Level | $26.80 | $92.26 |
| Average True Range (ATR) | 1.87 | 1.69 |
| MACD | -0.38 | -0.52 |
| Stochastic Oscillator | 15.40 | 65.75 |
Liftoff Mobile Inc is a marketing and retargeting platform that helps businesses maximize revenue through machine learning-powered solutions. Its AI-powered platform is designed to serve all verticals in the app ecosystem and is fully integrated to drive differentiated advertising performance for its customers across the app economy. The company deliver profitable users for app advertisers and help to maximize advertising revenue for apps that monetize with ads. Its solutions include: Marketers; Agencies; DSPs; Publishers; and Mobile Gaming.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.